About the Gastric Adenocarcinoma Session
Gastric adenocarcinoma, a prevalent type of stomach cancer, remains a significant focus in cancer research. Advances in molecular biology have shed light on the genetic mutations and pathways driving this malignancy, leading to the identification of key biomarkers and potential therapeutic targets. Research emphasizes the importance of early detection, with novel non-invasive screening methods, such as liquid biopsies, showing promise in identifying circulating tumor DNA. Immunotherapy, particularly checkpoint inhibitors, is emerging as a potent treatment strategy, offering hope for improved survival rates. Additionally, precision medicine, which tailors treatment based on an individual’s genetic profile, is revolutionizing the management of gastric adenocarcinoma, paving the way for more effective and personalized therapeutic approaches.
Topics Covered in Gastric Adenocarcinoma
Helicobacter Infection
Intestinal & Diffuse Types
Molecular Subtypes
Perioperative Chemotherapy
Claudin-Targeted Therapy
Checkpoint Inhibitors
Related Scientific Sessions at CIOC 2027
Why Attend the Gastric Adenocarcinoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Gastric Adenocarcinoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Gastric Adenocarcinoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Gastric Adenocarcinoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Gastric Adenocarcinoma Conference 2027 — FAQs
What is the Gastric Adenocarcinoma track at CIOC 2027?
The Gastric Adenocarcinoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Gastric Adenocarcinoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Gastric Adenocarcinoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Gastric Adenocarcinoma are all welcome — whether presenting or attending.
Can I present my research in the Gastric Adenocarcinoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Gastric Adenocarcinoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Gastric Adenocarcinoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.